February 26th 2025
By Danielle Ripley-Burgess
Being a young adult cancer survivor is bittersweet, bringing both unique struggles and unexpected blessings that shape my life, career and perspective.
February 21st 2025
By Jane Biehl Ph.D.
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
By Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 17th 2025
By Carla Deschamps
Faith, from my perspective, is believing in the unseen, and was something I rediscovered following my colon cancer diagnosis.
February 13th 2025
By Sue McCarthy
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's sarcoma diagnosis.
February 12th 2025
I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to others.
February 10th 2025
By Dr. John Oertle
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
By Ryan Scott
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine dehydrogenase deficiency.
By Karen Cohn
As a cancer survivor, I face added stress with an upcoming black belt test and "scanxiety" before my annual CT scan and oncology appointment.
By Dr. Gabriel A. Brooks
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.
Finding Humor in a Cancer Journey
Pancreatic Cancer on the Rise Among Younger Adults
Covering Every FDA Oncology Approval From October 2025
Why ‘There is Hope’ For Patients With Pancreatic Cancer